First Time Loading...

Animalcare Group PLC
LSE:ANCR

Watchlist Manager
Animalcare Group PLC Logo
Animalcare Group PLC
LSE:ANCR
Watchlist
Price: 244 GBX Market Closed
Updated: May 28, 2024
Section:
 

Relative Value

The Relative Value of one ANCR stock under the Base Case scenario is 426.43 GBX. Compared to the current market price of 244 GBX, Animalcare Group PLC is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ANCR Relative Value
Base Case
426.43 GBX
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2
P/S
P/S
Price to Sales
2
vs History
28
vs Industry
54
Median 3Y
2
Median 5Y
1.6
Industry
2.4
Forward
1.9
More Details
122.3
P/E
P/E
Price to Earnings
122.3
vs History
28
vs Industry
2
Median 3Y
89
Median 5Y
82.6
Industry
22.8
Forward
21.1
More Details
13.4
P/OCF
P/OCF
Price to OCF
13.4
vs History
30
vs Industry
30
Median 3Y
13.4
Median 5Y
11.3
Industry
17
More Details
75.3
P/FCFE
P/FCFE
Price to FCFE
75.3
vs History
25
vs Industry
8
Median 3Y
61.5
Median 5Y
54.8
Industry
23.2
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
26
vs Industry
42
Median 3Y
1.8
Median 5Y
1.4
Industry
2.1
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
31
vs Industry
53
Median 3Y
2
Median 5Y
1.8
Industry
2.6
Forward
1.9
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
49
vs Industry
57
Median 3Y
3.6
Median 5Y
3.3
Industry
5.1
More Details
10.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.2
vs History
39
vs Industry
33
Median 3Y
11.2
Median 5Y
9.7
Industry
13.5
Forward
12.5
More Details
22.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.1
vs History
73
vs Industry
20
Median 3Y
29.2
Median 5Y
33.7
Industry
16.9
Forward
16.2
More Details
13.5
EV/OCF
EV/OCF
Enterprise Value to OCF
13.5
vs History
36
vs Industry
31
Median 3Y
13.9
Median 5Y
12
Industry
15.8
More Details
17.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
17.6
vs History
41
vs Industry
22
Median 3Y
18
Median 5Y
17.1
Industry
17.7
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
25
vs Industry
43
Median 3Y
1.6
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

ANCR Competitors Multiples
Animalcare Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Animalcare Group PLC
LSE:ANCR
146.7m GBP 2 122.3 10.2 22.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
764.4B USD 21.3 124.5 60.9 69.3
DK
Novo Nordisk A/S
CSE:NOVO B
4.1T DKK 16.7 45.7 34.1 37.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
347.5B USD 4.1 9 11.1 14.5
US
Merck & Co Inc
NYSE:MRK
318.8B USD 5.2 138.2 34.5 56.3
UK
AstraZeneca PLC
LSE:AZN
186.5B GBP 5 37.5 174.5 278.3
CH
Roche Holding AG
SIX:ROG
182.4B CHF 3.1 15.9 9 10.7
CH
Novartis AG
SIX:NOVN
178.3B CHF 3.3 11.1 8.5 12.4
US
Pfizer Inc
NYSE:PFE
160.3B USD 2.9 -518.6 12.6 20.4
P/E Multiple
Earnings Growth
UK
Animalcare Group PLC
LSE:ANCR
Average P/E: 63
122.3
693%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
124.5
364%
DK
Novo Nordisk A/S
CSE:NOVO B
45.7
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9
-21%
US
Merck & Co Inc
NYSE:MRK
138.2
7 598%
UK
AstraZeneca PLC
LSE:AZN
37.5
175%
CH
Roche Holding AG
SIX:ROG
15.9
28%
CH
Novartis AG
SIX:NOVN
11.1
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -518.6
683%

See Also

Summary
ANCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANCR stock valuation using valuation multiples.
Wall Street Estimates
ANCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.